Sravan Kumar Emany
Chief Financial Officer; Director · 5 filings · Latest: Jun 16, 2026
Assertio Holdings, Inc.
Beam Therapeutics Inc.
Kyverna Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
IRWD | Emany Sravan Kumar | — | Nov 18, 2024 | Proposed Sale | $4.11 | 12,500 | $51.4K | — |